Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15979 | 613 | 47.6 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MONOCYTE SUBSETS | Author keyword | 21 | 49% | 5% | 31 |
2 | MONOCYTE HETEROGENEITY | Author keyword | 12 | 86% | 1% | 6 |
3 | MONOCYTE SUBSET | Author keyword | 12 | 86% | 1% | 6 |
4 | MONOCYTE SUBPOPULATIONS | Author keyword | 6 | 47% | 1% | 9 |
5 | EVA STUDY | Address | 5 | 63% | 1% | 5 |
6 | CD16 | Author keyword | 4 | 13% | 5% | 33 |
7 | CD14CD16 | Author keyword | 4 | 67% | 1% | 4 |
8 | CD14CD16MONOCYTES | Author keyword | 4 | 56% | 1% | 5 |
9 | U838 | Address | 3 | 43% | 1% | 6 |
10 | CD16 ANTIGEN | Author keyword | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MONOCYTE SUBSETS | 21 | 49% | 5% | 31 | Search MONOCYTE+SUBSETS | Search MONOCYTE+SUBSETS |
2 | MONOCYTE HETEROGENEITY | 12 | 86% | 1% | 6 | Search MONOCYTE+HETEROGENEITY | Search MONOCYTE+HETEROGENEITY |
3 | MONOCYTE SUBSET | 12 | 86% | 1% | 6 | Search MONOCYTE+SUBSET | Search MONOCYTE+SUBSET |
4 | MONOCYTE SUBPOPULATIONS | 6 | 47% | 1% | 9 | Search MONOCYTE+SUBPOPULATIONS | Search MONOCYTE+SUBPOPULATIONS |
5 | CD16 | 4 | 13% | 5% | 33 | Search CD16 | Search CD16 |
6 | CD14CD16 | 4 | 67% | 1% | 4 | Search CD14CD16 | Search CD14CD16 |
7 | CD14CD16MONOCYTES | 4 | 56% | 1% | 5 | Search CD14CD16MONOCYTES | Search CD14CD16MONOCYTES |
8 | CD16 ANTIGEN | 3 | 60% | 0% | 3 | Search CD16+ANTIGEN | Search CD16+ANTIGEN |
9 | CLASSICAL MONOCYTES | 3 | 60% | 0% | 3 | Search CLASSICAL+MONOCYTES | Search CLASSICAL+MONOCYTES |
10 | NON CLASSICAL MONOCYTES | 3 | 60% | 0% | 3 | Search NON+CLASSICAL+MONOCYTES | Search NON+CLASSICAL+MONOCYTES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CD14CD16 MONOCYTES | 45 | 66% | 7% | 42 |
2 | CD16 MONOCYTES | 33 | 63% | 5% | 33 |
3 | SPLENIC RESERVOIR | 14 | 64% | 2% | 14 |
4 | MONOCYTE SUBSETS | 10 | 29% | 5% | 29 |
5 | CARDIAC MACROPHAGES | 8 | 75% | 1% | 6 |
6 | CD14 CD16 MONOCYTES | 8 | 75% | 1% | 6 |
7 | LY 6CHIGH MONOCYTES | 8 | 100% | 1% | 5 |
8 | TISSUE RESIDENT MACROPHAGES | 7 | 33% | 3% | 18 |
9 | TISSUE MACROPHAGES | 6 | 16% | 5% | 33 |
10 | PREDICT CARDIOVASCULAR EVENTS | 6 | 25% | 3% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Monocytes and macrophages: developmental pathways and tissue homeostasis | 2014 | 80 | 117 | 21% |
Toward a refined definition of monocyte subsets | 2013 | 28 | 29 | 86% |
Macrophages: Development and Tissue Specialization | 2015 | 6 | 199 | 18% |
Origin and Functions of Tissue Macrophages | 2014 | 44 | 109 | 30% |
Monocyte recruitment during infection and inflammation | 2011 | 347 | 140 | 20% |
Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure | 2013 | 114 | 58 | 24% |
Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells | 2009 | 529 | 146 | 21% |
Monocyte and Macrophage Heterogeneity in the Heart | 2013 | 49 | 90 | 44% |
The cellular immune system in the post-myocardial infarction repair process | 2015 | 2 | 106 | 31% |
Role of innate and adaptive immune mechanisms in cardiac injury and repair | 2015 | 3 | 146 | 21% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EVA STUDY | 5 | 63% | 0.8% | 5 |
2 | U838 | 3 | 43% | 1.0% | 6 |
3 | MUNICIPAL HOSP HARLACHING | 2 | 67% | 0.3% | 2 |
4 | CLIN IMMUNOL TRANSPLANTAT | 2 | 26% | 0.8% | 5 |
5 | ASKLEPIOS HKLIN | 1 | 50% | 0.3% | 2 |
6 | BIOL MONONUCL PHAGOCYTE SYST | 1 | 50% | 0.3% | 2 |
7 | EVA STUDY GAUTING | 1 | 100% | 0.3% | 2 |
8 | KLIN NEPHROL KLIN IMMUNOL | 1 | 100% | 0.3% | 2 |
9 | POLISH AMER PAEDIAT | 1 | 17% | 1.0% | 6 |
10 | CLIN COOPERAT GRP AEROSOLS MED | 1 | 40% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000148989 | VASCULAR DENDRITIC CELLS//MOL MED CEMM//OPPENHEIMER ATHEROSCLEROSIS |
2 | 0.0000128508 | CROSS PRESENTATION//CHRIS BROWNE IMMUNOL IMMUNE DIS//CD207 |
3 | 0.0000125633 | TUMOR ASSOCIATED MACROPHAGES//TUMOR ASSOCIATED MACROPHAGE//TUMOUR ASSOCIATED MACROPHAGES |
4 | 0.0000118584 | FRACTALKINE//CXCL16//CX3CR1 |
5 | 0.0000080992 | EXPT LUNG//MACROPHAGE SECRETORY PRODUCTS//LUNG INFLAMMAT INFECT |
6 | 0.0000079620 | COUNTERFLOW CENTRIFUGATION ELUTRIATION//COUNTERFLOW CENTRIFUGAL ELUTRIATION//DUTTAPHRYNUS HIMALAYANUS |
7 | 0.0000076956 | CSF 1//MACROPHAGE COLONY STIMULATING FACTOR//M CSF |
8 | 0.0000065104 | MONOCYTE MATURATION//PEPTIDE FRACTION//TUMORCYTOTOXICITY |
9 | 0.0000061346 | NEUTROPHIL TO LYMPHOCYTE RATIO//LEUKOCYTE COUNT//WHITE BLOOD CELL COUNT |
10 | 0.0000060437 | CCR2 ANTAGONIST//CCR2//CCR2 ANTAGONISTS |